DocMe logo

DocMe

Your health and wellbeing at your fingertips.

3 employees · est. 2020 · Cambridge, United Kingdom

VS
GlycanAge logo

GlycanAge

Measure your real health. Predict your future health. Discover your bio-age with a test backed by 350+ research studies

47 employees · est. 2020 · Newcastle Upon Tyne, United...

GlycanAge is the larger of the two.

Side-by-Side Comparison

DocMe GlycanAge
Founded
2020 2020
Headquarters
Cambridge, United Kingdom Newcastle Upon Tyne, United Kingdom
Employees
3 47 larger
Industry
Health Care, Health insurance Biotechnology, Health Care
Funding Stage
Seed Select
Total Funding
$250.00K $13.40M
Funding Rounds
1 5
Services
Not tracked yet Biological Age Testing, Expert Advice, Personalized Longevity Journey
Target Customers
Not tracked yet Individuals seeking to understand and improve their biological age and overall health, Healthcare professionals seeking partnership opportunities
Taxonomy
HealthTech, MedTech, Personalized Health, Wellness Technology, Consumer Health, Healthcare Innovation, Preventive Medicine, Cardiovascular Health, Lifestyle Diseases, Health Awareness, Medical Technology, Data-driven Healthcare, Health Analytics, Aging Well, Self-management Health-Tech, Longevity, Glycobiology, Blood Biomarkers, Health Analysis, Lifestyle Choices, Age-Related Diseases, Research And Development, Health Monitoring, Biological Age, Healthcare Innovation
Website
DocMe.ai glycanage.com
DocMe logo

About DocMe

DocMe is a UK-based health tech startup, founded in 2020 with a mission to empower people to live longer, healthier lives. The company's slogan, "We empower people to live longer life healthily," encapsulates its core vision, focusing on preventative measures and empowering individuals to manage lif...

GlycanAge logo

About GlycanAge

GlycanAge is a biotechnology startup founded in 2020, headquartered in the United Kingdom. The company's slogan, "Measure your real health. Predict your future health. Discover your bio-age with a test backed by 300+ research studies," encapsulates its primary focus. The company offers a ground-bre...

We will tell you when either one moves

BounceWatch watches DocMe and GlycanAge for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at DocMe and GlycanAge — by email.

Frequently Asked Questions

DocMe — Your health and wellbeing at your fingertips.. GlycanAge — Measure your real health. Predict your future health. Discover your bio-age with a test backed by 350+ research studies. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
DocMe has raised $250.00K while GlycanAge has raised $13.40M.
DocMe and GlycanAge operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare DocMe with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at DocMe on 12 Sep 2024, and GlycanAge on 25 Feb 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes